Key statistics
On Wednesday, aTyr Pharma Inc (471A:DUS) closed at 0.715, 28.83% above the 52 week low of 0.555 set on Jan 29, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.72 |
|---|---|
| High | 0.72 |
| Low | 0.70 |
| Bid | -- |
| Offer | -- |
| Previous close | 0.735 |
| Average volume | 9.10k |
|---|---|
| Shares outstanding | 97.99m |
| Free float | 96.58m |
| P/E (TTM) | -- |
| Market cap | 86.23m USD |
| EPS (TTM) | -0.8345 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 18:32 GMT.
More ▼
Announcements
- aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
- aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
- aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results
- aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
